Asian Spectator

Men's Weekly

.

Positive Phase III Clinical Results for EirGenix's Proposed Tr...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
TAIPEI, March 23, 2021 /PRNewswire-AsiaNet/ -- In a press conference today, EirGenix, Inc. (6589.TT) announced that the Phase III clinical trial (Trial No.: EGC002, NCT03433313) of its breast cancer biosimilar, EG12014 (proposed trastuzumab biosimilar, also called EGI014), has met its primary ...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Grup penyintas judi ‘online’: Ruang berbagi trauma dan doa untuk sembuh bersama

(Wisely/Shutterstock)● Grup Facebook menjadi ruang penyintas judi ‘online’ untuk mengatasi masalah kecanduan.● Melalui cerita personal, mereka membangun ingatan bersama seputar...

Aktivisme kelas menengah: Sempat redup, kini bangkit melawan rezim

Ilustrasi masyarakat kelas menengah mengikuti aksi demo menyampaikan aspirasi.Odua Images/Shutterstock● Pada gelombang demo Agustus lalu, kesadaran politik kelas menengah kembali bangkit setelah...

The story of MTV: The downfall of music disrupter

The Buggles' song "Video Killed the Radio Star" became the first video clip to be broadcast on MTV.Ilustrasi: Rino/The Conversation, CC BYWhen The Buggles’ music video “Video Killed the Ra...